PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $830 | +121.9% | 17,357 | +88.7% | 0.00% | 0.0% |
Q2 2023 | $374 | -16.1% | 9,200 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $446 | +27.1% | 9,200 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $351 | -99.9% | 9,200 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $462,000 | +25.2% | 9,200 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $369,000 | +7.6% | 9,200 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $343,000 | -6.3% | 9,200 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $366,000 | +7.0% | 9,200 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $342,000 | -12.1% | 9,200 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $389,000 | -10.8% | 9,200 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $436,000 | -22.3% | 9,200 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $561,000 | +30.5% | 9,200 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $430,000 | -7.9% | 9,200 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $467,000 | +13.9% | 9,200 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $410,000 | +6.5% | 9,200 | +14.7% | 0.00% | +50.0% |
Q4 2019 | $385,000 | +42.1% | 8,019 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $271,000 | -24.9% | 8,019 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $361,000 | +19.5% | 8,019 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $302,000 | +9.8% | 8,019 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $275,000 | -27.1% | 8,019 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $377,000 | +39.6% | 8,019 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $270,000 | +24.4% | 8,019 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $217,000 | +61.9% | 8,019 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $134,000 | -16.2% | 8,019 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $160,000 | +8.8% | 8,019 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $147,000 | +86.1% | 8,019 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $79,000 | -9.2% | 8,019 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $87,000 | -22.3% | 8,019 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $112,000 | +100.0% | 8,019 | 0.0% | 0.00% | – |
Q2 2016 | $56,000 | +7.7% | 8,019 | 0.0% | 0.00% | – |
Q1 2016 | $52,000 | -67.5% | 8,019 | +62.8% | 0.00% | -100.0% |
Q4 2015 | $160,000 | +21.2% | 4,926 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $132,000 | -44.3% | 4,926 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $237,000 | – | 4,926 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
Chubb Ltd | 8,180 | $368,000 | 1.82% |